{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:21:35Z","timestamp":1763727695863},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0498","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T22:04:27Z","timestamp":1585865067000},"page":"741-750","source":"Crossref","is-referenced-by-count":3,"title":["Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done"],"prefix":"10.1507","volume":"67","author":[{"given":"Naohisa","family":"Tamura","sequence":"first","affiliation":[{"name":"Research Support Center, Shizuoka General Hospital, Shizuoka 420-8527, Japan"},{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Yamada","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Torii-Hanakita","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kyo","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Kosugi","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"},{"name":"Department of Medical Genetics, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Yonemoto","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"},{"name":"Department of Medical Genetics, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kotani","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Usui","sequence":"additional","affiliation":[{"name":"Research Support Center, Shizuoka General Hospital, Shizuoka 420-8527, Japan"},{"name":"Department of Medical Genetics, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhide","family":"Inoue","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 Naruse M, Tanaka T, Otani S, Ogawa J, Tanabe M, et al. (2009) PHAS-J Study Group\u2014a study on the frequency of PHAS in hypertensive patients in Japan using the network of the National Hospital Organization (NHO). Folia Endocrinologica Japonica 85: 246S (In Japanese)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193\u2013202.","DOI":"10.1291\/hypres.27.193"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, et al. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80\u201385.","DOI":"10.1001\/archinternmed.2007.33"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243\u20131248.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Savard S, Amar L, Plouin P-F, Steichen O (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62: 331\u2013336.","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530\u2013537.","DOI":"10.1161\/HYPERTENSIONAHA.117.10263"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T (1995) Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 18: 370\u2013373.","DOI":"10.1007\/BF03347840"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, et al. (1997) Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 20: 85\u201390.","DOI":"10.1291\/hypres.20.85"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J 58: 711\u2013721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"10","doi-asserted-by":"publisher","unstructured":"11 Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, et al. (2007) Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50: 424\u2013431.","DOI":"10.1161\/HYPERTENSIONAHA.107.091827"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K (2001) Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab 86: 4292\u20134298.","DOI":"10.1210\/jcem.86.9.7867"},{"key":"12","doi-asserted-by":"publisher","unstructured":"13 Agharazii M, Douville P, Grose JH, Lebel M (2001) Captopril suppression <i>versus<\/i> salt loading in confirming primary aldosteronism. Hypertension 37: 1440\u20131443.","DOI":"10.1161\/01.HYP.37.6.1440"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129\u20131135.","DOI":"10.1016\/S0895-4356(03)00177-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Muller FB, Sealey JE, Case DB, Atlas SA, Pickering TG, et al. (1986) The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 80: 633\u2013644.","DOI":"10.1016\/0002-9343(86)90819-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193\u2013202.","DOI":"10.1291\/hypres.27.193"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Nishikawa T, Omura M, Kawaguchi M, Takatsu A, Satoh F, et al. (2016) Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr J 63: 1065\u20131080.","DOI":"10.1507\/endocrj.EJ16-0304"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, et al. (2017) Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay. Hypertension 70: 334\u2013341.","DOI":"10.1161\/HYPERTENSIONAHA.117.09078"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Umemura S, Arima H, Arima S, Asayama K, Dohi Y, et al. (2019) The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/7\/67_EJ19-0498\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T03:28:13Z","timestamp":1596252493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/7\/67_EJ19-0498\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0498","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}